Cargando…

Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy

The search for safe and efficient new antifungal compounds for agriculture has led to more efforts in finding new modes of action. This involves the discovery of new molecular targets, including coding and non-coding RNA. Rarely found in plants and animals but present in fungi, group I introns are o...

Descripción completa

Detalles Bibliográficos
Autores principales: Malbert, Bastien, Labaurie, Virginie, Dorme, Cécile, Paget, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254303/
https://www.ncbi.nlm.nih.gov/pubmed/37298936
http://dx.doi.org/10.3390/molecules28114460
_version_ 1785056610221031424
author Malbert, Bastien
Labaurie, Virginie
Dorme, Cécile
Paget, Eric
author_facet Malbert, Bastien
Labaurie, Virginie
Dorme, Cécile
Paget, Eric
author_sort Malbert, Bastien
collection PubMed
description The search for safe and efficient new antifungal compounds for agriculture has led to more efforts in finding new modes of action. This involves the discovery of new molecular targets, including coding and non-coding RNA. Rarely found in plants and animals but present in fungi, group I introns are of interest as their complex tertiary structure may allow selective targeting using small molecules. In this work, we demonstrate that group I introns present in phytopathogenic fungi have a self-splicing activity in vitro that can be adapted in a high-throughput screening to find new antifungal compounds. Ten candidate introns from different filamentous fungi were tested and one group ID intron found in F. oxysporum showed high self-splicing efficiency in vitro. We designed the Fusarium intron to act as a trans-acting ribozyme and used a fluorescence-based reporter system to monitor its real time splicing activity. Together, these results are opening the way to study the druggability of such introns in crop pathogen and potentially discover small molecules selectively targeting group I introns in future high-throughput screenings.
format Online
Article
Text
id pubmed-10254303
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102543032023-06-10 Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy Malbert, Bastien Labaurie, Virginie Dorme, Cécile Paget, Eric Molecules Article The search for safe and efficient new antifungal compounds for agriculture has led to more efforts in finding new modes of action. This involves the discovery of new molecular targets, including coding and non-coding RNA. Rarely found in plants and animals but present in fungi, group I introns are of interest as their complex tertiary structure may allow selective targeting using small molecules. In this work, we demonstrate that group I introns present in phytopathogenic fungi have a self-splicing activity in vitro that can be adapted in a high-throughput screening to find new antifungal compounds. Ten candidate introns from different filamentous fungi were tested and one group ID intron found in F. oxysporum showed high self-splicing efficiency in vitro. We designed the Fusarium intron to act as a trans-acting ribozyme and used a fluorescence-based reporter system to monitor its real time splicing activity. Together, these results are opening the way to study the druggability of such introns in crop pathogen and potentially discover small molecules selectively targeting group I introns in future high-throughput screenings. MDPI 2023-05-31 /pmc/articles/PMC10254303/ /pubmed/37298936 http://dx.doi.org/10.3390/molecules28114460 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Malbert, Bastien
Labaurie, Virginie
Dorme, Cécile
Paget, Eric
Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy
title Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy
title_full Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy
title_fullStr Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy
title_full_unstemmed Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy
title_short Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy
title_sort group i intron as a potential target for antifungal compounds: development of a trans-splicing high-throughput screening strategy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254303/
https://www.ncbi.nlm.nih.gov/pubmed/37298936
http://dx.doi.org/10.3390/molecules28114460
work_keys_str_mv AT malbertbastien groupiintronasapotentialtargetforantifungalcompoundsdevelopmentofatranssplicinghighthroughputscreeningstrategy
AT labaurievirginie groupiintronasapotentialtargetforantifungalcompoundsdevelopmentofatranssplicinghighthroughputscreeningstrategy
AT dormececile groupiintronasapotentialtargetforantifungalcompoundsdevelopmentofatranssplicinghighthroughputscreeningstrategy
AT pageteric groupiintronasapotentialtargetforantifungalcompoundsdevelopmentofatranssplicinghighthroughputscreeningstrategy